Industry-wide coverage policy expands reimbursement framework for donor-derived cell-free DNA testingSupports iMDx's commercial strategy in ...
Peter Attia warns that simplicity is crushing nuance in science. I agree—so I took a closer look at his own argument on LDL, ...
Background Pancreatic ductal adenocarcinoma (PDAC) is largely refractory to immune checkpoint blockade, owing to its ...
Background Catastrophic healthcare expenditure (CHE) poses significant financial burdens on households globally, particularly ...
Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly recognised for benefits beyond glycaemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results